Open Access Open Access  Restricted Access Subscription Access

An Essential Parameters of Clonazepam Include Medical Uses, Seizures, Anxiety as well as Muscle Disorders, Contra Indications, Adverse Effects, Tolerance as well as Withdrawl, Overdose, Detection in Biological Fluids, Pregnancy, Pharmacology and Pharmacok

Karthik Jayanth Y., Muralinath E., Sheethal U., Guruprasad M., Madhavilatha C., Renuka U.

Abstract


A benzodiazepine medication plays an important role regarding inhibition and treatment of anxiety disorders, seizures, bipolar mania, agitation related to psychosis, obsessive–compulsive disorder (OCD), and akathisia. It is a long-acting benzodiazepine. It consists of anxiolytic, anticonvulsant, sedative, hypnotic, and skeletal muscle relaxant properties. It is consumed orally (swallowed by mouth) in a typical manner but is also used intravenously. Effects start within one hour and last between eight and twelve hours in adults. Common side effects are sleepiness, weakness, poor coordination, difficulty concentrating, and agitation. Long-term use may lead to tolerance, dependence, and life-threatening withdrawal symptoms if stopped in an abrupt manner. One-third of people who take benzodiazepines for more than four weeks become dependent. The risk of suicide increases, especially for those who are already depressed. Use during pregnancy may lead to harm to the fetus. Clonazepam binds to GABAA receptors, thus enhancing the effect of the chief inhibitory neurotransmitter γ-aminobutyric acid (GABA).


Full Text:

PDF

References


"Paxam data sheet." (2023, October 18). Medsafe. Retrieved March 14, 2024, from https://www.medsafe.govt.nz

"Clonazepam international." (n.d.). Drugs.com. Retrieved from https://www.drugs.com

"Clonazepam use during pregnancy." (2020, May 4). Drugs.com. Retrieved May 17, 2020, from https://www.drugs.com

Longo, L. P., & Johnson, B. (2000, April). Addiction: Part I. Benzodiazepines—Side effects, abuse risk and alternatives. American Family Physician, 61(7), 2121–2128.

Hupp, J. R., Tucker, M. R., & Ellis, E. (2013). Contemporary oral and maxillofacial surgery (E-book ed.). Elsevier Health Sciences.

Ebel, S., & Schütz, H. (1977, February). Studies on the detection of clonazepam and its main metabolites considering thin-layer chromatography discrimination of nitrazepam and its major metabolic products. Arzneimittel-Forschung, 27(2), 325–337.

Steentoft, A., & Linnet, K. (2009, January). Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002–2007. Forensic Science International, 184(1–3), 74–79. https://doi.org/10.1016/j.forsciint.2008.12.004

Cooper, G. (Ed.). (2007). Therapeutic uses of botulinum toxin. Humana Press.

Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008, August). Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics. Acta Neurologica Scandinavica, 118(2), 69–86. https://doi.org/10.1111/j.1600-0404.2008.01004.x

"Clonazepam." (n.d.). American Society of Health-System Pharmacists. Retrieved August 15, 2015.

Basit, H., & Kahwaji, C. I. (2024). Clonazepam. In StatPearls. StatPearls Publishing.

Koubeissi, M. (2016). Intravenous clonazepam in status epilepticus. Epilepsy Currents, 16(2), 89–90. https://doi.org/10.5698/1535-7511-16.2.89

Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., et al. (2021, November). Benzodiazepines: Uses, dangers, and clinical considerations. Neurology International, 13(4), 594–607. https://doi.org/10.3390/neurolint13040059

Dodds, T. J. (2017, March). Prescribed benzodiazepines and suicide risk: A review of the literature. The Primary Care Companion for CNS Disorders, 19(2). https://doi.org/10.4088/PCC.16r02037

Fischer, J., & Ganellin, C. R. (2006). Analogue-based drug discovery. John Wiley & Sons.

Shorter, E. (2005). A historical dictionary of psychiatry. Oxford University Press.

"Top 300 of 2023." (2025). ClinCalc. Retrieved August 12, 2025.

"Clonazepam drug usage statistics, United States, 2014–2023." (2025). ClinCalc. Retrieved August 17, 2025.

Martino, D., & Cavanna, A. E. (Eds.). (2013). Advances in the neurochemistry and neuropharmacology of Tourette syndrome. Elsevier Science.

Fisher, G. L. (2009). Encyclopedia of substance abuse prevention, treatment, & recovery. SAGE Publications.


Refbacks

  • There are currently no refbacks.